PlasmaGen Biosciences
PlasmaGen BioSciences is an Indian Bio-pharmaceutical organization specializing exclusively in Plasma Protein Therapy. Headquartered in Bangalore- India.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
* | $27.0m | Late VC | |
| Total Funding | 000k | ||
Related Content
PlasmaGen BioSciences is an Indian biopharmaceutical company that specializes in Plasma Protein Therapy. The company is dedicated to providing a wide range of safe plasma products aimed at improving the health and quality of life of patients in India and the SAARC (South Asian Association for Regional Cooperation) region. PlasmaGen operates in the healthcare and biopharmaceutical market, focusing on plasma-derived therapies which are essential for treating various medical conditions such as immune deficiencies, bleeding disorders, and other critical illnesses.
The business model of PlasmaGen revolves around the development, production, and distribution of plasma protein products. The company generates revenue by selling these specialized therapies to hospitals, clinics, and healthcare providers. PlasmaGen's commitment to quality and safety ensures that their products meet stringent regulatory standards, thereby gaining trust and recognition in the market.
PlasmaGen serves a diverse clientele that includes healthcare professionals, hospitals, and patients who require plasma protein therapies. By focusing on innovation and affordability, the company aims to make these life-saving treatments accessible to a broader population.
Keywords: Plasma Protein Therapy, Biopharmaceutical, Healthcare, India, SAARC, Immune Deficiencies, Bleeding Disorders, Plasma Products, Quality, Safety.